Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases

por Nebigil, Canan G.
Publicado 2017

Updates in Anthracycline-Mediated Cardiotoxicity

por Nebigil, Canan G., Désaubry, Laurent
Publicado 2018

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments

por Audebrand, Anais, Désaubry, Laurent, Nebigil, Canan G.
Publicado 2020

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

por Nebigil, Canan G., Chan, Michael W. Y.
Publicado 2023

Correction: Nguyen T.L., et al. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. J. Dev. Biol. 2013, 1, 20–31

por Nguyen, Thu Lan, Gasser, Adeline, Nebigil, Canan G.
Publicado 2020

Discovery of GPCR ligands for probing signal transduction pathways

por Brogi, Simone, Tafi, Andrea, Désaubry, Laurent, Nebigil, Canan G.
Publicado 2014

Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential

por Thuaud, Frédéric, Ribeiro, Nigel, Nebigil, Canan G., Désaubry, Laurent
Publicado 2013

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside

por Nebigil, Canan G., Chan, Michael W. Y., Rassaf, Tienush
Publicado 2020

The flavagline FL3 interferes with the association of Annexin A2 with the eIF4F initiation complex and transiently stimulates the translation of annexin A2 mRNA

por Grindheim, Ann Kari, Patil, Sudarshan S., Nebigil, Canan G., Désaubry, Laurent, Vedeler, Anni
Publicado 2023

Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells

por Qureshi, Rehana, Kindo, Michel, Arora, Himanshu, Boulberdaa, Mounia, Steenman, Marja, Nebigil, Canan G.
Publicado 2017

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies

por Hsu, Po-Yen, Mammadova, Aynura, Benkirane-Jessel, Nadia, Désaubry, Laurent, Nebigil, Canan G.
Publicado 2021

Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses

por Nebigil, Canan G., Moog, Christiane, Vagner, Stéphan, Benkirane-Jessel, Nadia, Smith, Duncan R., Désaubry, Laurent
Publicado 2020

Evidence for reciprocal network interactions between injured hearts and cancer

por Guler, Melisa N., Tscheiller, Nathalie M., Sabater-Molina, Maria, Gimeno, Juan R., Nebigil, Canan G.
Publicado 2022

Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27

por Bernard, Yohann, Ribeiro, Nigel, Thuaud, Frédéric, Türkeri, Gülen, Dirr, Ronan, Boulberdaa, Mounia, Nebigil, Canan G., Désaubry, Laurent
Publicado 2011

Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development

por Arora, Himanshu, Boulberdaa, Mounia, Qureshi, Rehana, Bitirim, Verda, Gasser, Adeline, Messaddeq, Nadia, Dolle, Pascal, Nebigil, Canan G.
Publicado 2016

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity

por Qureshi, Rehana, Yildirim, Onur, Gasser, Adeline, Basmadjian, Christine, Zhao, Qian, Wilmet, Jean-Philippe, Désaubry, Laurent, Nebigil, Canan G.
Publicado 2015

Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity

por Szatkowski, Cécilia, Vallet, Judith, Dormishian, Mojdeh, Messaddeq, Nadia, Valet, Phillippe, Boulberdaa, Mounia, Metzger, Daniel, Chambon, Pierre, Nebigil, Canan G.
Publicado 2013

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1

por Gasser, Adeline, Brogi, Simone, Urayama, Kyoji, Nishi, Toshishide, Kurose, Hitoshi, Tafi, Andrea, Ribeiro, Nigel, Désaubry, Laurent, Nebigil, Canan G.
Publicado 2015

SFPH proteins as therapeutic targets for a myriad of diseases

por Wang, Dong, Tabti, Redouane, Elderwish, Sabria, Djehal, Amel, Chouha, Nora, Pinot, Franck, Yu, Peng, Nebigil, Canan G., Désaubry, Laurent
Publicado 2020

Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions

por Dormishian, Mojdeh, Turkeri, Gulen, Urayama, Kyoji, Nguyen, Thu Lan, Boulberdaa, Mounia, Messaddeq, Nadia, Renault, Gilles, Henrion, Daniel, Nebigil, Canan G.
Publicado 2013